OKT3 delays rejection crises after heart transplantation

Transplant Proc. 1989 Feb;21(1 Pt 3):2497-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Cyclosporins / therapeutic use
  • Graft Rejection*
  • Heart Transplantation*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Muromonab-CD3
  • Postoperative Complications / prevention & control

Substances

  • Antibodies, Monoclonal
  • Cyclosporins
  • Immunosuppressive Agents
  • Muromonab-CD3